ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Interventional Pain Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,219Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 25

$905K Total Retail Price of All Prescriptions

Rank: 1 out of 25

537 Patients Receiving at Least One Drug in Part D
28%Patients 65 Years and Older
74% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

64% of this provider’s 537 patients filled at least one prescription for a schedule two drug, compared to an average of 29%.

Schedule Three
Controlled Substances

60% of this provider’s 537 patients filled at least one prescription for a schedule three drug, compared to an average of 43%.

Risky Drugs to Seniors

4% of this provider’s 3,270 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 5%.

Brand Name Drugs

13% of this provider’s prescriptions were for brand-name drugs, compared to an average of 15%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $62 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 10.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
HYDROCODONE-ACETAMINOPHEN 3,742 891 S3 1 1
OXYCODONE HCL-ACETAMINOPHEN 1,258 211 S2 2 3
FENTANYL 1,157 238 S2 10 3 6
MORPHINE SULFATE ER 837 99 S2 4 7
TRAMADOL HCL 682 194 5 4
ZOLPIDEM TARTRATE 474 63 6 12
CEPHALEXIN 461 124 7 28
ENDOCET 419 154 S2 8 11
TIZANIDINE HCL 369 22 9 5
CYCLOBENZAPRINE HCL 366 45 R 10 9
OXYCONTIN 359 85 S2 11 15
GABAPENTIN 347 88 12 2
OXYCODONE HCL 332 21 S2 13 8
PROMETHAZINE HCL 307 34 R 14 26
OPANA ER 258 36 S2 15 22
MELOXICAM 237 53 16 13
TRAZODONE HCL 210 95 17 24
BACLOFEN 208 31 18 23
AMITRIPTYLINE HCL 148 0 R 19 16
METHOCARBAMOL 140 21 R 20 20
CIPROFLOXACIN HCL 113 39 21 42
NEXIUM 108 20 22 43
NAPROXEN 104 28 23 31
CYMBALTA 103 30 24 14
MORPHINE SULFATE 88 29 S2 25 29
LYRICA 87 0 26 10
FUROSEMIDE 83 0 27 44
VOLTAREN 80 35 28 33
TOPIRAMATE 76 0 29 34
OXYCODONE-ACETAMINOPHEN 74 49 S2 30 17
LIDODERM 65 17 31 27
OMEPRAZOLE 62 22 32 48
ROPINIROLE HCL 62 19 32 35
CLONAZEPAM 58 21 34 41
CITALOPRAM HBR 55 12 35 52
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 13, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.